German firm Syntellix opens first overseas facility in Singapore
The orthopaedic implant maker projects that overall investment will reach S$200 million by 2024, with a potential cumulative revenue of S$500 million by then
Add BT as a preferred source
Sharon See
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
SYNTELLIX, a German firm that pioneered the use of bioabsorbable bone implants, opened its first overseas production site in Singapore on Tuesday, amid expectations of strong growth in the medical technology industry in this region.
While initial investment in the facility falls within an undisclosed "single-digit" million dollars, Syntellix founder, CEO and executive chairman Utz Claassen projected overall investment to reach S$200 million by 2024, with a potential cumulative revenue of S$500 million by then.
Copyright SPH Media. All rights reserved.
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Beijing’s calculated silence on the Iran war
DPM Gan warns of 3 structural shifts to the global system that will bring greater challenges – and opportunities
